Educational Intervention Can Cut Inappropriate PPI Prescriptions

This article originally appeared here.
Share this content:
Educational Intervention Can Cut Inappropriate PPI Prescriptions
Educational Intervention Can Cut Inappropriate PPI Prescriptions

MONDAY, March 9, 2015 (HealthDay News) -- A monthly educational intervention paired with a web-based quality improvement tool is feasible for increasing the proportion of inappropriate proton pump inhibitor (PPI) prescriptions discontinued at hospital discharge, according to a study published online Feb. 24 in the Journal of Hospital Medicine.

Emily G. McDonald, M.D., from the McGill University Health Center in Montreal, and colleagues conducted a before-after study involving a monthly educational intervention paired with a web-based quality improvement tool to reduce inappropriate PPI prescriptions. Data were compared for 464 consecutively admitted patients in the pre-intervention control group and 640 consecutively admitted patients in the intervention group.

The researchers found that before hospitalization, 44 percent of patients were using a PPI. Only 54 percent of evaluated patients had an evidence-based indication for ongoing use. There was an increase in the proportion of PPIs discontinued at hospital discharge, from 7.7 percent per month in the six months before the intervention to 18.5 percent per month post-intervention (P = 0.03).

"We significantly reduced discharge prescriptions for PPIs through the implementation of an educational initiative paired with a web-based quality improvement tool," the authors write. "An active interventional strategy is likely required considering the increasingly recognized and preventable adverse events associated with PPI misuse."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »